The Discounted Cash Flow (DCF) valuation of Celon Pharma SA (CLN.WA) is (21.52) PLN. With the latest stock price at 22.00 PLN, the upside of Celon Pharma SA based on DCF is -197.8%.
Based on the latest price of 22.00 PLN and our DCF valuation, Celon Pharma SA (CLN.WA) is a sell. selling CLN.WA stocks now will result in a potential gain of 197.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.7% - 9.5% | 8.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (34.74) - (15.93) | (21.52) |
| Upside | -257.9% - -172.4% | -197.8% |